Last reviewed · How we verify
NCT07126821
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
trial testing No Interventions in Brain (Nervous System) Cancers in 100,000 participants. Currently enrolling.
31 December 2030
Quick facts
| Lead sponsor | Xiangya Hospital of Central South University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100,000 |
| Start date | 15 May 2025 |
| Primary completion | 31 December 2030 |
| Estimated completion | 31 December 2030 |
| Sites | 1 location across China |
Drugs / interventions tested
- No Interventions — full drug profile →
Conditions studied
- Brain (Nervous System) Cancers — all drugs for Brain (Nervous System) Cancers →
- Brain Arterial Disease — all drugs for Brain Arterial Disease →
- Neuro-Degenerative Disease — all drugs for Neuro-Degenerative Disease →
- Brain Tumors — all drugs for Brain Tumors →
Sponsor
Xiangya Hospital of Central South University
Who can join
Eligibility, any sex, with Brain (Nervous System) Cancers or Brain Arterial Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to develop an innovative, comprehensive, and explainable AI vision-language foundation model (VLM) to advance the diagnosis and interpretation of brain diseases using multi-modal data. We will include patient demographics, medical imaging data (such as MRI, CT, and PET scans), histopathological data, genomic data when available, and other necessary laboratory examinations and tests to establish a screening and diagnostic model for brain diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07126821
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Interventions
Trials testing the same drug.
- NCT07473284 — Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients · not yet recruiting
- NCT07413380 — Effects of Arm Measurements on Upper Limb Skills and Reaction Time · NA · not yet recruiting
- NCT07536711 — Ego-Tucking: Exploring the Psychological Mechanisms of the "Fo-xi" Phenomenon Among University Students · completed
- NCT07409376 — Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in t · NA · not yet recruiting
- NCT07356115 — Association of High PainDETECT Scores With Pain Region and Diagnosis in Patients Attending a Musculoskeletal and Sports · recruiting
Other recruiting trials for Brain (Nervous System) Cancers
Currently open trials in the same condition.
- NCT05859659 — Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE) · recruiting
Other Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07482670 — Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases · not yet recruiting
- NCT07412223 — Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery · Phase 4 · not yet recruiting
- NCT07369960 — Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Glo · NA · recruiting
- NCT07369999 — Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07309913 — China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07126821 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xiangya Hospital of Central South University
- Last refreshed: 17 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07126821.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing